NCT06277297 Prognotic Role of CMR in Takotsubo Syndrome
| NCT ID | NCT06277297 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cagliari |
| Condition | Takotsubo Cardiomyopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2022-11-09 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2022-11-09 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this observational registry is to develop a comprehensive clinical and imaging score (incorporating echocardiography and cardiac magnetic resonance data) that enhances risk stratification for patients with Takotsubo syndrome. The secondary objectives of this registry are as follows: Investigate the diagnostic value of cardiac magnetic resonance parameters in predicting in-hospital and long-term outcomes in patients with Takotsubo syndrome. Compare the proposed risk stratification score for patients with Takotsubo syndrome with previously existing scores. Investigate the contribution of machine learning models in predicting in-hospital and long-term outcomes compared to standard clinical scores. The design and rationale of this registry are available at 10.1097/RTI.0000000000000709
Eligibility Criteria
Inclusion Criteria: * Takotsubo syndrome diagnosis (according to Position Statement of the European Society of Cardiology Heart Failure Association) * Adult patients ( \> 18y old) * Availability at baseline of clinical variables, standard transthoracic echocardiography, and cardiovascular magnetic resonance acquisition Exclusion Criteria: * \<18 y old * Lack of transthoracic echocardiography and cardiovascular magnetic resonance examinations * Preexisting cardiomyopathies * Previous myocardial infarction * Suspected or known prior irreversible myocardial damage * Valvular heart disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06277297 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Takotsubo Cardiomyopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06277297 currently recruiting?
Yes, NCT06277297 is actively recruiting participants. Contact the research team at riccardo.cau@unica.it for enrollment information.
Where is the NCT06277297 trial being conducted?
This trial is being conducted at Cagliari, Italy.
Who is sponsoring the NCT06277297 clinical trial?
NCT06277297 is sponsored by University of Cagliari. The trial plans to enroll 350 participants.